Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Sci Rep ; 2: 575, 2012.
Article in English | MEDLINE | ID: mdl-22893853

ABSTRACT

Drug resistance is a challenge that can be addressed using nanotechnology. We focused on the resistance of the bacteria Pseudomonas aeruginosa and investigated, using Atomic Force Microscopy (AFM), the behavior of a reference strain and of a multidrug resistant clinical strain, submitted to two antibiotics and to an innovative antibacterial drug (CX1). We measured the morphology, surface roughness and elasticity of the bacteria under physiological conditions and exposed to the antibacterial molecules. To go further in the molecules action mechanism, we explored the bacterial cell wall nanoscale organization using functionalized AFM tips. We have demonstrated that affected cells have a molecularly disorganized cell wall; surprisingly long molecules being pulled off from the cell wall by a lectin probe. Finally, we have elucidated the mechanism of action of CX1: it destroys the outer membrane of the bacteria as demonstrated by the results on artificial phospholipidic membranes and on the resistant strain.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Nanotechnology/methods , Pseudomonas aeruginosa/drug effects , Anti-Bacterial Agents/chemistry , Microscopy, Atomic Force/methods , Pseudomonas aeruginosa/cytology
2.
Antiviral Res ; 88(3): 343-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20854844

ABSTRACT

Facing the lack in specific antiviral treatment, it is necessary to develop new means of prevention. In the case of the Coronaviridae this family is now recognized as including potent human pathogens causing upper and lower respiratory tract infections as well as nosocomial ones. Within the purpose of developing new antiseptics molecules, the antiseptic virucidal activity of two calix[4]arene derivatives, the tetra-para-sulfonato-calix[4]arene (C[4]S) and the 1,3-bis(bithiazolyl)-tetra-para-sulfonato-calix[4]arene (C[4]S-BTZ) were evaluated toward the human coronavirus 229E (HCoV 229E). Comparing these results with some obtained previously with chlorhexidine and hexamidine, (i) these two calixarenes did not show any cytotoxicity contrary to chlorhexidine and hexamidine, (ii) C[4]S showed as did hexamidine, a very weak activity against HCoV 229E, and (iii) the C[4]S-BTZ showed a stronger activity than chlorhexidine, i.e. 2.7 and 1.4log10 reduction in viral titer after 5min of contact with 10⁻³mol L⁻¹ solutions of C[4]S-BTZ and chlorhexidine, respectively. Thus, the C[4]S-BTZ appeared as a promising virucidal (antiseptic) molecule.


Subject(s)
Anti-Infective Agents, Local/chemical synthesis , Anti-Infective Agents, Local/toxicity , Calixarenes/toxicity , Disinfectants/chemical synthesis , Disinfectants/toxicity , Virus Inactivation , Benzamidines/toxicity , Calixarenes/chemistry , Cell Line , Chlorhexidine/toxicity , Coronavirus 229E, Human/drug effects , Coronavirus 229E, Human/growth & development , Coronavirus Infections/prevention & control , Coronavirus Infections/virology , Dose-Response Relationship, Drug , Humans , Viral Load , Virus Inactivation/drug effects
3.
Pathol Biol (Paris) ; 58(1): 46-51, 2010 Feb.
Article in French | MEDLINE | ID: mdl-19892486

ABSTRACT

UNLABELLED: Three problems at the moment: multidrug-resistant bacteria, healthcare-associated infections, and decrease of active antibiotics. We have an urgent need of new antibacterials, with an innovative mechanism of action, in order to avoid too quickly bacterial resistance. The first interface between bacteria and antibiotics is the bacterial cell wall. It is a very interesting target, as far as some components or motives are highly conserved between genus or species, and wall destabilization conduct rapidly to bacterial lysis. However, few methods are at our disposal to study rapidly impact of such antibacterials on the structure, composition or functions of the bacterial cell wall. The paraguanidinoethylcalix[4]arene (Cx1) is a new cationic antibacterial drug, with a broad spectrum, not toxic, active on multidrug-resistant bacteria, with a possible parietal target, but with unknown kind of activity (i.e. bactericidal or bacteriostatic). We thus developed, at the same time as the realization of the time-kill curves, a technique to stain bacteria with two dyes: SYTO9 and propidium iodide (PI), to follow the membrane permeability modifications, due to Cx1 exposure. The obtained results demonstrate, for Escherichia coli ATCC 25922, that Cx1 possesses a bactericidal activity, concentration-dependent, with a gradual achievement of membrane permeability, time- and concentration-dependent, with the presence of filamentous bacteria. IN CONCLUSION: the SYTO9-PI double staining, allows a simple and fast detection, easy to implement, of the impact of new antibacterial on the bacterial wall; and Cx1 interacts well with the bacterial wall, pulling in the end a loss of membrane integrity.


Subject(s)
Anti-Bacterial Agents/pharmacology , Calixarenes/pharmacology , Cell Membrane Permeability/drug effects , Cell Wall/drug effects , Escherichia coli/drug effects , Microbial Sensitivity Tests/statistics & numerical data , Anti-Bacterial Agents/chemistry , Calixarenes/chemistry , Cell Wall/metabolism , Coloring Agents , Dose-Response Relationship, Drug , Drug Discovery , Drug Evaluation, Preclinical , Drug Resistance, Multiple, Bacterial , Escherichia coli/metabolism , Escherichia coli/ultrastructure , Microscopy, Fluorescence , Molecular Structure , Organic Chemicals , Propidium , Staining and Labeling/methods , Time Factors
4.
Clin Microbiol Infect ; 16(5): 432-8, 2010 May.
Article in English | MEDLINE | ID: mdl-19456831

ABSTRACT

Use of antiseptics and disinfectants is essential in infection control practices in hospital and other healthcare settings. In this study, the in vitro activity of a new promising compound, para-guanidinoethylcalix[4]arene (Cx1), has been evaluated in comparison with hexamidine (HX) and chlorhexidine (CHX), two older cationic antiseptics. The MICs for 69 clinical isolates comprising methicillin-resistant Staphylococcus aureus, methicillin-sensitive S. aureus, coagulase-negative staphylococci (CoNS) (with or without mecA), vancomycin-resistant enterococci, Enterobacteriaceae producing various beta-lactamases and non-fermenting bacilli (Pseudomonas aeruginosa, Acinetobacter baumanii, Stenotrophomonas maltophilia) were determined. Cx1 showed similar activity against S. aureus, CoNS and Enterococcus spp., irrespective of the presence of mecA or van genes, or associated resistance genes, with very good activity against CoNS (MIC <1 mg/L). Variable activities were observed against Enterobacteriaceae; the MICs determined seemed to be dependent both on the genus (MICs of 2, 8 and 64 mg/L for Escherichia coli, Klebsiella pneumoniae and Yersinia enterocolitica, respectively) and on the resistance phenotype production of [Extended Spectrum beta-Lactase (ESBLs) or other beta-lactamases; overproduction of AmpC]. Poor activity was found against non-fermenting bacilli, irrespective of the resistance phenotype. CHX appeared to be the most active compound against all strains, with broad-spectrum and conserved activity against multidrug-resistant strains. HX showed a lower activity, essentially against Gram-positive strains. Consequently, the differences observed with respect to Cx1 suggest that they are certainly not the consequence of antibiotic resistance phenotypes, but rather the result of membrane composition modifications (e.g. of lipopolysaccharide), or of the presence of (activated) efflux-pumps. These results raise the possibility that Cx1 may be a potent new antibacterial agent of somewhat lower activity but significantly lower toxicity than CHX.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Calixarenes/pharmacology , Chlorhexidine/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Benzamidines/pharmacology , Cations/pharmacology , Drug Resistance, Multiple, Bacterial , Microbial Sensitivity Tests
5.
Pathol Biol (Paris) ; 55(10): 465-71, 2007 Dec.
Article in French | MEDLINE | ID: mdl-17913392

ABSTRACT

Microbial cell surface properties play a central role in controlling phenomena such as bacterial adhesion and biofilm formation (on stent or on prosthesis for example). The quantification of these properties and the understanding of interactions with antibacterial compounds remain difficult, in view of the complex and dynamic nature of the cell wall constituents. Various approaches, macroscopic, microscopic or molecular, have been developed. Two of them interest us today: (i) microelectrophoresis, which permits to evaluate surface modifications by measuring eletrophoretic mobility; and (ii) atomic force microscopy (AFM), a high resolution imaging device, which allows investigations at nanometric scale. After brief presentation of principles and instrumentations, the aim of this article is to present the different applications of these techniques in Microbiology, and to discuss interest of these tools in order to investigate mechanism of action of antibacterial compounds.


Subject(s)
Anti-Bacterial Agents/pharmacology , Electrophoresis/methods , Microscopy, Atomic Force/methods , Bacterial Adhesion , Bacterial Physiological Phenomena , Bacteriology , Cell Membrane/drug effects , Sensitivity and Specificity
6.
Pathol Biol (Paris) ; 54(8-9): 470-6, 2006.
Article in French | MEDLINE | ID: mdl-17023121

ABSTRACT

We present here the results concerning the antibacterial properties evaluation of para-guanidinoethylcalix[4]arene, compared with its constitutive monomer, the para-guanidinoethylphenol, and hexamidine (Hexomédine), an antiseptic from the diamidine family widely used in therapeutic, chosen as a reference in this study for its resemblance in terms of functional groups. Antibacterial activities of those three compounds were evaluated by microdilution methods, in Mueller Hinton broth, onto 5 bacterial strains: Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923 & ATCC 29213 and Enterococcus faecalis ATCC 29212, according to CA-SFM and CLSI (formerly NCCLS) approved standards. In parallel, the effects of these three compounds on MRC-5 eukaryotic cell viability were evaluated with MTT assay. The results obtained here confirm a lack of activity for the monomer compound (MIC> or =512 mg/l) and a real antibacterial activity for the calixarene, comparable to hexamidine. This activity is expressed, both on Gram+and Gram- bacteria (MIC=4 mg/l for E. coli, 8 mg/l on both S. aureus strains) and at a lesser degree on E. faecalis and P. aeruginosa (MIC=32 mg/l). Similarly, both compounds, monomer and calixarene, slightly induce any modification on MRC-5 cells viability, and this until 168 h of treatment for concentrations reaching 10(-4) mol/L while hexamidine demonstrates a significant and increasing effect during the time of experiment and this for 100 to 1000 times lower concentrations. Thus, this study tends to confirm the significance of the organization of the para-guanidinoethylphenol monomer into its cyclic calixarenic tetramer for the gain of an antibacterial activity, similar to a widely used antiseptic one.


Subject(s)
Anti-Bacterial Agents/pharmacology , Guanidines/pharmacology , Benzamidines/pharmacology , Enterococcus faecalis/drug effects , Escherichia coli/drug effects , Guanidines/chemistry , Microbial Sensitivity Tests , Molecular Conformation , Molecular Structure , Staphylococcus aureus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...